Changes in equity
in € millions |
Subscribed share capital |
Additional paid-in capital |
Cashflow hedge reserve |
Cumulative translation reserves |
Other (legal) reserves and undistributed profit |
Shareholders’ equity |
Noncontrolling interests |
Group equity |
||
|
||||||||||
Balance at January 1, 2017 |
504 |
745 |
3 |
(47) |
5,348 |
6,553 |
481 |
7,034 |
||
Profit for the period |
– |
– |
– |
– |
240 |
240 |
21 |
261 |
||
Other comprehensive income |
– |
– |
(11) |
9 |
2 |
– |
– |
– |
||
Comprehensive income for the period |
– |
– |
(11) |
9 |
242 |
240 |
21 |
261 |
||
Dividend |
– |
– |
– |
– |
– |
– |
(8) |
(8) |
||
Equity-settled transactions |
– |
– |
– |
– |
7 |
7 |
– |
7 |
||
Issue of common shares |
1 |
(1) |
– |
– |
– |
– |
– |
– |
||
Share repurchase |
– |
– |
– |
– |
(144) |
(144) |
– |
(144) |
||
Balance at March 31, 2017 |
505 |
744 |
(8) |
(38) |
5,453 |
6,656 |
494 |
7,150 |
||
|
|
|
|
|
|
|
|
|
||
Balance at December 31, 2017 |
505 |
769 |
15 |
(549) |
5,125 |
5,865 |
442 |
6,307 |
||
Impact adoption IFRS 9 and IFRS 15 |
– |
– |
– |
– |
(46) |
(46) |
(5) |
(51) |
||
Balance at January 1, 2018 * |
505 |
769 |
15 |
(549) |
5,079 |
5,819 |
437 |
6,256 |
||
Profit for the period |
– |
– |
– |
– |
253 |
253 |
21 |
274 |
||
Other comprehensive income |
– |
– |
(1) |
(72) |
(46) |
(119) |
(6) |
(125) |
||
Comprehensive income for the period |
– |
– |
(1) |
(72) |
207 |
134 |
15 |
149 |
||
Dividend |
– |
– |
– |
– |
– |
– |
(2) |
(2) |
||
Equity-settled transactions |
– |
– |
– |
– |
8 |
8 |
– |
8 |
||
Issue of common shares |
1 |
(1) |
– |
– |
– |
– |
– |
– |
||
Balance at March 31, 2018 |
506 |
768 |
14 |
(621) |
5,294 |
5,961 |
450 |
6,411 |
Shareholders’ equity
Shareholders’ equity increased from €5.9 billion at year-end 2017 to €6.0 billion at the end of March 31, 2018, mainly due to the net effect of:
- Profit for the period of €253 million
- Adverse currency effects of €72 million (including taxes)
- Actuarial losses of €46 million (including taxes)
- Opening balance adjustment for IFRS 9 and IFRS 15 of €46 million negative
Dividend
Our dividend policy is to pay a stable to rising dividend. A final 2017 dividend of €1.94 per share is proposed for approval at the AGM, which would make a total 2017 dividend of €2.50 (2016: €1.65) per share, up 52%.
There will be a stock dividend option, up to a maximum of 40% of the total dividend amount, with cash dividend as default. Please refer to the final page of this report for dividend payment dates.
In addition, a €1 billion special cash dividend, as advance proceeds for the separation of the Specialty Chemicals business, was paid on December 7, 2017.